Cornea · 2026
Osimertinib-Associated Benign Ocular Hyperpigmentation: A Case Report.
СтатьяНазвание и аннотация: Перевод в очереди
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…
Ошибки и ограничения
История · было → стало
Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.
Wijesinghe Nuhansi, Chin Jennifer, Chung Ann, Samarawickrama Chameen
Аннотация
PURPOSE: To report a case of benign conjunctival and corneal epithelial hyperpigmentation associated with long-term osimertinib use.
METHODS: observational case report.
RESULTS: An incidental finding of bilateral benign hyperpigmentation of the conjunctiva and corneal epithelium was noted in an Asian woman in her sixth decade. Pigmentation involved the caruncle and extended to the lid margins in both eyes. Her medical history is significant for an 8-year history of non-small-cell lung cancer, for which she has been treated with osimertinib for 4 years.
OBSERVATIONS: An incidental finding of bilateral benign hyperpigmentation of the conjunctiva and corneal epithelium was noted in an Asian woman in her sixth decade. Pigmentation involved the caruncle and extended to the lid margins in both eyes. Her medical history is significant for an 8-year history of non-small-cell lung cancer, for which she has been treated with osimertinib for 4 years.
CONCLUSIONS AND IMPORTANCE: Although rare, recognizing osimertinib-associated hyperpigmentation is clinically important as it needs to be differentiated from primary acquired melanosis, which carries a risk of progression to conjunctival melanoma.
METHODS: observational case report.
RESULTS: An incidental finding of bilateral benign hyperpigmentation of the conjunctiva and corneal epithelium was noted in an Asian woman in her sixth decade. Pigmentation involved the caruncle and extended to the lid margins in both eyes. Her medical history is significant for an 8-year history of non-small-cell lung cancer, for which she has been treated with osimertinib for 4 years.
OBSERVATIONS: An incidental finding of bilateral benign hyperpigmentation of the conjunctiva and corneal epithelium was noted in an Asian woman in her sixth decade. Pigmentation involved the caruncle and extended to the lid margins in both eyes. Her medical history is significant for an 8-year history of non-small-cell lung cancer, for which she has been treated with osimertinib for 4 years.
CONCLUSIONS AND IMPORTANCE: Although rare, recognizing osimertinib-associated hyperpigmentation is clinically important as it needs to be differentiated from primary acquired melanosis, which carries a risk of progression to conjunctival melanoma.